0,990  0,001  UGT1A6 substrate
0,976  0,001  CYP2C9 substrate
0,976  0,001  CYP2C19 substrate
0,975  0,001  CYP2D6 substrate
0,964  0,002  Transcription factor NF kappa B inhibitor
0,957  0,003  CYP1A2 substrate
0,949  0,001  UGT1A1 substrate
0,949  0,003  Teratogen
0,948  0,001  Anesthetic general
0,945  0,003  Embryotoxic
0,940  0,003  Cardiotonic
0,936  0,003  CYP3A4 substrate
0,935  0,002  Chemopreventive
0,934  0,005  Apoptosis agonist
0,927  0,002  Proliferative diseases treatment
0,914  0,000  Na+ K+ transporting ATPase inhibitor
0,892  0,003  Antineoplastic (sarcoma)
0,892  0,004  Carcinogenic
0,879  0,002  Diuretic
0,878  0,003  DNA damaging
0,869  0,005  Antineoplastic (lung cancer)
0,864  0,004  Antineoplastic (ovarian cancer)
0,857  0,005  Antineoplastic (breast cancer)
0,853  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,851  0,004  Respiratory analeptic
0,849  0,003  NOS2 expression inhibitor
0,844  0,004  Antineoplastic (non-small cell lung cancer)
0,842  0,004  Prostate cancer treatment
0,838  0,005  Antineoplastic (colorectal cancer)
0,833  0,004  Antineoplastic (pancreatic cancer)
0,828  0,003  Cytotoxic
0,827  0,004  UDP-glucuronosyltransferase substrate
0,826  0,005  Antineoplastic (colon cancer)
0,815  0,004  Antineoplastic (glioma)
0,815  0,004  Analeptic
0,805  0,004  Heart failure treatment
0,776  0,003  Antiparasitic
0,777  0,004  Cholesterol antagonist
0,767  0,002  Antihelmintic
0,762  0,004  Antineoplastic (brain cancer)
0,752  0,005  Antineoplastic (cervical cancer)
0,738  0,001  ATPase inhibitor
0,758  0,021  Antiinflammatory
0,744  0,009  Antileukemic
0,740  0,005  Antineoplastic (melanoma)
0,733  0,005  Caspase 3 stimulant
0,724  0,004  Antineoplastic (glioblastoma multiforme)
0,712  0,008  Mutagenic
0,697  0,004  Antineoplastic (renal cancer)
0,682  0,010  Antibacterial
0,656  0,004  Transcription factor STAT inhibitor
0,644  0,003  Transcription factor STAT3 inhibitor
0,650  0,013  Antihypercholesterolemic
0,641  0,008  Immunosuppressant
0,631  0,006  Antineoplastic (multiple myeloma)
0,624  0,013  Sensitization
0,612  0,005  Antineoplastic (lymphoma)
0,601  0,010  Nitric oxide antagonist
0,595  0,006  Antineoplastic enhancer
0,594  0,011  Hepatic disorders treatment
0,585  0,005  Antineoplastic (liver cancer)
0,587  0,011  Cardioprotectant
0,578  0,004  Antidiarrheal
0,583  0,025  Antineoplastic (solid tumors)
0,564  0,012  Antifungal
0,562  0,014  NOS3 expression inhibitor
0,568  0,031  TNF expression inhibitor
0,552  0,044  Caspase 9 stimulant
0,531  0,025  Immunostimulant
0,508  0,004  Antineoplastic antibiotic
0,508  0,006  Interferon gamma antagonist
0,500  0,007  Antineoplastic (squamous cell carcinoma)
0,508  0,019  Apoptosis antagonist
0,491  0,005  UGT2B7 substrate
0,494  0,021  Cytostatic
0,480  0,008  Anesthetic
0,468  0,007  Contraceptive
0,469  0,014  Antineoplastic (endocrine cancer)
0,459  0,005  Interleukin 6 antagonist
0,468  0,018  ICAM1 expression inhibitor
0,436  0,009  Sodium/bile acid cotransporter inhibitor
0,451  0,026  Antioxidant
0,435  0,010  Hepatoprotectant
0,433  0,011  Antiviral (Herpes)
0,433  0,017  Angiogenesis stimulant
0,440  0,028  UGT1A9 substrate
0,430  0,024  UGT2B4 substrate
0,403  0,004  Cholesterol synthesis inhibitor
0,408  0,010  Prostate disorders treatment
0,403  0,010  Antiviral (Influenza)
0,405  0,013  Antineoplastic (carcinoma)
0,402  0,010  Topoisomerase II inhibitor
0,402  0,012  Melanin inhibitor
0,395  0,005  Antifungal enhancer
0,411  0,022  Antihypoxic
0,416  0,032  Chemoprotective
0,413  0,036  AR expression inhibitor
0,391  0,017  P-glycoprotein inhibitor
0,381  0,008  Peptidyltransferase inhibitor
0,428  0,056  Antipruritic, allergic
0,379  0,025  DNA synthesis inhibitor
0,364  0,012  Lipocortins synthesis antagonist
0,377  0,027  Antineoplastic (osteosarcoma)
0,341  0,008  Topoisomerase I inhibitor
0,343  0,012  Antiviral (Influenza A)
0,343  0,016  Antiacne
0,353  0,028  Antineoplastic (lymphocytic leukemia)
0,357  0,039  Antiprotozoal (Leishmania)
0,316  0,006  Contraceptive male
0,316  0,011  Acute respiratory distress syndrome (ARDS) treatment
0,323  0,019  Prostatic (benign) hyperplasia treatment
0,310  0,009  Psychosexual dysfunction treatment
0,334  0,042  Hypoglycemic
0,298  0,012  DNA intercalator
0,294  0,013  Alkylator
0,309  0,030  RNA-directed DNA polymerase inhibitor
0,280  0,004  Antirickettsial
0,277  0,003  Glycine receptor agonist
0,309  0,036  Antihypertriglyceridemic
0,276  0,012  Aldose reductase substrate
0,332  0,071  Antithrombotic
0,281  0,020  UGT2B15 substrate
0,293  0,037  Wound healing agent
0,279  0,025  Acaricide
0,263  0,011  Antihemorrhagic
0,305  0,055  Antipyretic
0,325  0,076  Bone diseases treatment
0,271  0,022  Protein kinase stimulant
0,256  0,008  Selectin antagonist
0,300  0,052  Free radical scavenger
0,255  0,008  Antineoplastic, alkylator
0,238  0,004  Protein 50S ribosomal subunit inhibitor
0,310  0,080  Antihypertensive
0,235  0,008  Growth stimulant
0,262  0,038  UGT1A4 substrate
0,297  0,076  Interleukin 2 agonist
0,241  0,020  Adenylate cyclase inhibitor
0,253  0,034  Antipruritic, non-allergic
0,251  0,038  Neurotrophic factor enhancer
0,220  0,009  Antineoplastic alkaloid
0,285  0,076  Spasmolytic
0,282  0,075  Lipoprotein disorders treatment
0,271  0,065  Tumour necrosis factor alpha release inhibitor
0,216  0,013  Topoisomerase II alpha inhibitor
0,228  0,027  UGT2B9 substrate
0,231  0,034  Amylase inhibitor
0,205  0,012  Antibiotic
0,223  0,031  Skin whitener
0,209  0,017  Antifungal (Cryptococcus)
0,257  0,065  Vasodilator
0,246  0,055  Antiarrhythmic
0,267  0,081  Antiosteoporotic
0,320  0,145  Cyclophilin D inhibitor
0,320  0,145  Antidiabetic
0,191  0,019  Choleretic
0,192  0,022  Microtubule formation inhibitor
0,182  0,016  Androgen antagonist
0,273  0,109  Antineoplastic (small cell lung cancer)
0,294  0,131  CYP2C19 inhibitor
0,187  0,023  Expectorant
0,179  0,015  Chronic obstructive bronchitis treatment
0,172  0,009  Anabolic
0,187  0,026  Farnesoid X receptor antagonist
0,165  0,005  Glycine receptor antagonist
0,172  0,012  Transcription factor NF kappa B stimulant
0,196  0,038  Insulin secretagoues
0,163  0,006  Bile acid receptor antagonist
0,201  0,050  UGT1A3 substrate
0,253  0,106  Antimycobacterial
0,210  0,066  Platelet adhesion inhibitor
0,252  0,114  CYP3A4 inhibitor
0,150  0,016  Antiviral (Trachoma)
0,144  0,012  Estrogen agonist
0,139  0,010  ATPase (Vacuolar H+) inhibitor
0,151  0,028  AMP-activated protein kinase stimulant
0,144  0,024  Toll-Like receptor 4 antagonist
0,207  0,089  Hypolipemic
0,158  0,042  Cyclooxygenase 3 inhibitor
0,152  0,039  Ca2+-transporting ATPase inhibitor
0,176  0,064  Antihelmintic (Nematodes)
0,125  0,014  Postmenopausal disorders treatment
0,199  0,089  VCAM1 expression inhibitor
0,115  0,005  RNA-directed RNA polymerase stimulant
0,114  0,009  Antitreponemal
0,113  0,009  Antimycoplasmal
0,100  0,014  Androgen agonist
0,127  0,042  Estrogen antagonist
0,124  0,040  Dementia treatment
0,092  0,010  H+/K+-transporting ATPase inhibitor
0,164  0,083  Toxic, respiratory center
0,119  0,039  Vascular dementia treatment
0,093  0,013  Hypercalcemia treatment
0,100  0,020  Prokinetic
0,138  0,059  Antihyperlipoproteinemic
0,136  0,057  DNA polymerase I inhibitor
0,198  0,124  Radioprotector
0,158  0,085  UGT2B10 substrate
0,087  0,014  Antibiotic Glycopeptide-like
0,129  0,056  Contraceptive female
0,155  0,083  Arachidonic acid antagonist
0,108  0,037  Antispirochetal
0,082  0,012  Lipocortins synthesis agonist
0,193  0,128  Interleukin agonist
0,116  0,052  UGT2B1 substrate
0,109  0,046  UGT2B11 substrate
0,158  0,103  Septic shock treatment
0,063  0,008  Antibiotic Aminoglycoside-like
0,100  0,046  Actinic keratosis treatment
0,112  0,059  Interleukin 2 antagonist
0,058  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,113  0,063  Endometrios treatment
0,054  0,007  Protein 30S ribosomal subunit inhibitor
0,061  0,015  Estrogen receptor alpha agonist
0,050  0,006  Motilin receptor agonist
0,052  0,008  Cholesterol absorption inhibitor
0,112  0,069  Protein-tyrosine phosphatase 1B inhibitor
0,103  0,060  Sulfotransferase substrate
0,055  0,012  Hypogonadism treatment
0,043  0,004  GRP78 expression inhibitor
0,243  0,205  Antiarthritic
0,124  0,088  Neurotrophic factor
0,110  0,074  Cell adhesion inhibitor
0,054  0,019  Estrogen receptor beta agonist
0,055  0,021  Microtubule stabilization
0,122  0,091  Lipid peroxidase inhibitor
0,197  0,168  Immunomodulator
0,110  0,082  Antiviral (Hepatitis B)
0,065  0,038  Aromatase inhibitor
0,083  0,056  T cell inhibitor
0,030  0,004  Antibiotic Macrolide-like
0,129  0,103  Pregnane X receptor agonist
0,059  0,034  Acetyl-CoA transferase 2 inhibitor
0,089  0,065  SULT1E1 substrate
0,125  0,106  NOS3 expression enhancer
0,022  0,006  Telomerase stimulant
0,034  0,022  Glucocorticoid antagonist
0,066  0,055  Andropause treatment
0,036  0,027  5-Alpha-reductase inhibitor
0,022  0,014  Corticosteroid-like
0,113  0,106  Antineoplastic (uterine cancer)
0,033  0,027  Tubulin agonist
0,017  0,013  Progesterone agonist
0,118  0,114  Genotoxic
0,059  0,057  Phosphofructokinase-1 inhibitor
0,043  0,042  Glucose-6-phosphate isomerase inhibitor

